Physician profile
Alphonza Faison
NPI 1558844340
$1,085.35
in general payments reported to CMS, 2019-2025
9 companies · $437 in 2025
The $437 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $255 · 2022: $95.46 · 2023: $78.56 · 2024: $220 · 2025: $437.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $735.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $735.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Indivior INC. | $417.04 | 2023-2025 | Sublocade |
| Uswm, LLC | $208.01 | 2021-2022 | |
| Forte Bio-Pharma LLC | $197.84 | 2022-2025 | Prolate, Nalocet, Tanlor |
| Braeburn INC. | $119.04 | 2024-2025 | Brixadi |
| Abbvie INC. | $56.28 | 2021 | |
| Collegium Pharmaceutical, INC. | $34.68 | 2025 | Belbuca |
| Neurocrine Biosciences, INC. | $20.50 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $19.66 | 2022 | |
| Esperion Therapeutics, INC. | $12.30 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alphonza Faison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.